Products Ordering Resources About

Featured Product

UsiRNA
A Revolution in siRNA Technology
- Significantly Improve siRNA Efficacy
- Benefit from Alternative IP Landscape


  Learn More!
  
  

  June
Specials

Last Chance Stocked Nucleotides | Buy 1, Get 1: Free!


Order must be placed online using offer code: BG2. Limit one free vial (up to 10 µmoles) of equal or lesser value per customer. Offer valid through 10/31/11. Cannot be combined with any other offers or discounts.

Research Update

UNA Modified siRNA for Improved Efficacy

TriLink is proud to introduce unlocked nucleic acid (UNA) oligonucleotides, flexible RNA mimics that enable modulation of affinity and specificity, as well as UNA modified siRNA, or UsiRNA, for improved gene knockdown. UNA is an RNA analogue also known as 2',3'-seco-RNA, where the C2'-C3' bond is absent, making the molecule very flexible. This gives UNA the property of decreased binding affinity towards a complementary strand. A 5-10°C decrease in melting temperature (Tm) is seen per UNA insertion with additive effect, allowing a gradual decrease in the thermostability by introduction into DNA or RNA oligonucleotides. UNA modifications can be strategically placed to induce either a lack of mismatch discrimination or an increase in mismatch discrimination.(1)

UNA StructureDue to these unique properties, UNA monomer substitution in an oligonucleotide permits modulation of the thermodynamic stability of various nucleic acid structures such as RNA:DNA duplexes, quadruplexes, aptamers and i-motifs. UNA has demonstrated utility in antisense oligonucleotide therapeutics, including single strand and gapmer oligonucleotides due to compatibility with RNase H activity.

Of particular interest are the UNA modified siRNAs, known as UsiRNAs, which show potent gene silencing and dramatically reduced off-target effects.(2) It was demonstrated by Marina Biotech that replacement of the two overhang bases with UNA, coupled with an additional UNA-U at the 5' end of the guide strand and a position 7 modification of the passenger strand with UNA greatly reduced the off-target effects and in many cases enhanced overall efficacy of the siRNA through reduced toxicity. This work was largely confirmed through the efforts of the laboratory of Jorgen Kjems at Aarhus University in Denmark along with numerous collaborators.(3) They investigated a large number of different modifications and discovered that UsiRNA performed best and stood out from the rest of the modifications as giving the most dependable reduction of off-target effects and hence overall efficacy.

To place an order for a UsiRNA, send us your siRNA sequences that currently have off-target effects. We will replace the appropriate bases with UNA. We expect that you will see a reduction in off-target effects in almost every case.

Learn more about UsiRNA
Learn more about UNA properties

 

Featured Question

Q. What is the difference between siRNA and UsiRNA?


A. UsiRNA has been shown to reduce off-target events by greater than 10-fold over standard siRNA.(4) In a recent publication by Vaish et. al. it was rationalized that the reduction in off-target effects was due to a combination of increased loading of the appropriate strand into the RNA induced silencing complex (RISC) and a decrease in silencing by a microRNA-like mechanism.

UsiRNA contains UNA substitutions to the standard siRNA construct in the antisense (guide) strand at position 7. (See the figure below.) Substitution at position 7 of the antisense strand is shown to reduce microRNA-like off-target effects while maintaining siRNA potency. The sense (passenger) strand has a single 5' UNA substitution. This 5' modification prevents undesired loading of the sense (passenger) strand into RISC and eliminates potential for off-target RNAi-mediated activity (IC50 as low as ~10 pM). Both strands are modified with two 3' UNA modifications to increase nuclease stability. Because UNA is not RNA, UsiRNA is not covered by the current siRNA patent suite.

Learn more about UsiRNA
Ask An Expert | View FAQs

 

UsiRNA

 

 
Twitter Twitter Twitter Facebook Facebook Linked In Linked In Linked In
Products | Ordering | Resources | About
© 2010 TriLink BioTechnologies, Inc. | All Rights Reserved